Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Kevin Le, PharmD, BCOP
Articles
In a Nod to Precision Oncology, the FDA Approves Revumenib
Kevin Le, PharmD, BCOP;Ayaa Kobaissi, PharmD Candidate;Eugenia Kwon, PharmD Candidate;Maidah Farooq;Ami Ali, PharmD, BCOP
February 12th 2025The approval marks a significant milestone in the treatment of a rare and aggressive subtype of acute leukemia.
Read More
Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies
Amir Ali, PharmD, BCOP;Kevin Le, PharmD, BCOP;Tanjia Toma, PharmD Candidate;Soumar Haddad, PharmD Candidate;Fleuri Dindar, PharmD Candidate;Bryan Ceballos, PharmD Candidate
December 26th 2024Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.
Read More
Latest Updated Articles
Published: June 12th 2025 | Updated: June 16th 2025
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Published: June 10th 2025 | Updated: June 12th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
Published: June 2nd 2025 | Updated: June 11th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 3rd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Published: May 30th 2025 | Updated: June 5th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
